ATE275950T1 - Intravenösen verabreichung von valproat zur behandlung von migränekopfschmerzen - Google Patents
Intravenösen verabreichung von valproat zur behandlung von migränekopfschmerzenInfo
- Publication number
- ATE275950T1 ATE275950T1 AT00928865T AT00928865T ATE275950T1 AT E275950 T1 ATE275950 T1 AT E275950T1 AT 00928865 T AT00928865 T AT 00928865T AT 00928865 T AT00928865 T AT 00928865T AT E275950 T1 ATE275950 T1 AT E275950T1
- Authority
- AT
- Austria
- Prior art keywords
- treatment
- migraine headache
- valproate
- intravenous administration
- therapy
- Prior art date
Links
- 206010027599 migraine Diseases 0.000 title abstract 3
- 208000019695 Migraine disease Diseases 0.000 title abstract 2
- 238000001990 intravenous administration Methods 0.000 title abstract 2
- AEQFSUDEHCCHBT-UHFFFAOYSA-M sodium valproate Chemical compound [Na+].CCCC(C([O-])=O)CCC AEQFSUDEHCCHBT-UHFFFAOYSA-M 0.000 title abstract 2
- 229940102566 valproate Drugs 0.000 title abstract 2
- 238000002560 therapeutic procedure Methods 0.000 abstract 3
- 206010019233 Headaches Diseases 0.000 abstract 1
- 230000001154 acute effect Effects 0.000 abstract 1
- 231100000869 headache Toxicity 0.000 abstract 1
- 230000002035 prolonged effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13241699P | 1999-05-04 | 1999-05-04 | |
| PCT/US2000/012317 WO2000066109A2 (en) | 1999-05-04 | 2000-05-04 | Intravenous valproate for acute treatment of migraine headache |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE275950T1 true ATE275950T1 (de) | 2004-10-15 |
Family
ID=22453956
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT00928865T ATE275950T1 (de) | 1999-05-04 | 2000-05-04 | Intravenösen verabreichung von valproat zur behandlung von migränekopfschmerzen |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US7141247B2 (de) |
| EP (1) | EP1181012B1 (de) |
| AT (1) | ATE275950T1 (de) |
| AU (1) | AU4703500A (de) |
| CA (1) | CA2372806A1 (de) |
| DE (1) | DE60013811T2 (de) |
| DK (1) | DK1181012T3 (de) |
| ES (1) | ES2228521T3 (de) |
| PT (1) | PT1181012E (de) |
| WO (1) | WO2000066109A2 (de) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE60013811T2 (de) | 1999-05-04 | 2005-11-17 | Keith R. Edwards | Intravenösen verabreichung von valproat zur behandlung von migränekopfschmerzen |
| US20050159985A1 (en) * | 2003-11-21 | 2005-07-21 | Bertram Carl T. | System and method of stratifying intervention groups and comparison groups based on disease severity index scores and ranges |
| MY147767A (en) | 2004-06-16 | 2013-01-31 | Janssen Pharmaceutica Nv | Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders |
| CA2609185A1 (en) | 2005-05-20 | 2006-11-30 | Ahmed F. Abdel-Magid | Process for preparation of sulfamide derivatives |
| US8691867B2 (en) | 2005-12-19 | 2014-04-08 | Janssen Pharmaceutica Nv | Use of benzo-fused heterocycle sulfamide derivatives for the treatment of substance abuse and addiction |
| US8492431B2 (en) | 2005-12-19 | 2013-07-23 | Janssen Pharmaceutica, N.V. | Use of benzo-fused heterocycle sulfamide derivatives for the treatment of obesity |
| US8937096B2 (en) | 2005-12-19 | 2015-01-20 | Janssen Pharmaceutica Nv | Use of benzo-fused heterocyle sulfamide derivatives for the treatment of mania and bipolar disorder |
| US8497298B2 (en) | 2005-12-19 | 2013-07-30 | Janssen Pharmaceutica Nv | Use of benzo-fused heterocycle sulfamide derivatives for lowering lipids and lowering blood glucose levels |
| US8716231B2 (en) | 2005-12-19 | 2014-05-06 | Janssen Pharmaceutica Nv | Use of benzo-fused heterocycle sulfamide derivatives for the treatment of pain |
| AU2007253814A1 (en) | 2006-05-19 | 2007-11-29 | Janssen Pharmaceutica N.V. | Co-therapy for the treatment of epilepsy |
| WO2010008776A2 (en) | 2008-06-23 | 2010-01-21 | Janssen Pharmaceutica Nv | Disposable patch and reusable sensor assembly for use in medical device localization and mapping systems |
| US8815939B2 (en) | 2008-07-22 | 2014-08-26 | Janssen Pharmaceutica Nv | Substituted sulfamide derivatives |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5432176A (en) * | 1988-11-29 | 1995-07-11 | The John Hopkins University | Method of retarding the progression of chronic renal failure |
| US5102913A (en) | 1991-07-01 | 1992-04-07 | Halikas James A | Treatment for cocaine use employing valproic acid |
| US5767117A (en) * | 1994-11-18 | 1998-06-16 | The General Hospital Corporation | Method for treating vascular headaches |
| PL345364A1 (en) * | 1998-06-22 | 2001-12-17 | American Biogenetic Sciences | The use of valproic acid analog for the treatment and prevention of migraine and affective illness |
| DE60013811T2 (de) | 1999-05-04 | 2005-11-17 | Keith R. Edwards | Intravenösen verabreichung von valproat zur behandlung von migränekopfschmerzen |
-
2000
- 2000-05-04 DE DE60013811T patent/DE60013811T2/de not_active Expired - Fee Related
- 2000-05-04 DK DK00928865T patent/DK1181012T3/da active
- 2000-05-04 WO PCT/US2000/012317 patent/WO2000066109A2/en not_active Ceased
- 2000-05-04 PT PT00928865T patent/PT1181012E/pt unknown
- 2000-05-04 EP EP00928865A patent/EP1181012B1/de not_active Expired - Lifetime
- 2000-05-04 ES ES00928865T patent/ES2228521T3/es not_active Expired - Lifetime
- 2000-05-04 AU AU47035/00A patent/AU4703500A/en not_active Abandoned
- 2000-05-04 CA CA002372806A patent/CA2372806A1/en not_active Abandoned
- 2000-05-04 AT AT00928865T patent/ATE275950T1/de not_active IP Right Cessation
-
2001
- 2001-12-27 US US10/034,981 patent/US7141247B2/en not_active Expired - Fee Related
-
2005
- 2005-07-01 US US11/173,922 patent/US7163689B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| WO2000066109A2 (en) | 2000-11-09 |
| PT1181012E (pt) | 2005-02-28 |
| ES2228521T3 (es) | 2005-04-16 |
| CA2372806A1 (en) | 2000-11-09 |
| DE60013811T2 (de) | 2005-11-17 |
| US20050245611A1 (en) | 2005-11-03 |
| EP1181012A2 (de) | 2002-02-27 |
| WO2000066109A3 (en) | 2001-02-15 |
| US7163689B2 (en) | 2007-01-16 |
| AU4703500A (en) | 2000-11-17 |
| DK1181012T3 (da) | 2005-01-24 |
| US7141247B2 (en) | 2006-11-28 |
| DE60013811D1 (de) | 2004-10-21 |
| US20020156131A1 (en) | 2002-10-24 |
| EP1181012B1 (de) | 2004-09-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60236413D1 (de) | Inhibitoren von hmgb1 zur behandlung von gewebekrankheiten | |
| ATE201597T1 (de) | Verabreichung von riluzol zur behandlung von neuro-aids | |
| ATE230757T1 (de) | Verabreichung von peptidylheterocyclen zur behandlung von thrombin in zusammenhang stehenden krankheiten | |
| DE60013811D1 (de) | Intravenösen verabreichung von valproat zur behandlung von migränekopfschmerzen | |
| DK420385A (da) | Antioestrogent laegemiddel til perkutan indgift | |
| ATE305307T1 (de) | Reboxetin zur behandlung von migränekopfschmerzen | |
| DE69213814D1 (de) | Melatoninderivate zur Behandlung von Schlafstörungen und zur Pre-Anästhesie | |
| FI922325A0 (fi) | Oral sammansaettning foer botning av inflammatoriska tarmkanalsjukdomar. | |
| NO961478L (no) | Levobupivacaine anvendelig for kontroll av kronisk smerte | |
| ATE321548T1 (de) | Verwendung von statin zur behandlung von hauterkrankungen | |
| ATE350030T1 (de) | Nordihydroguaiaretinsäurederivate zur behandlung von tumoren | |
| ATE390928T1 (de) | Zusammensetzungen zur behandlung von hauterkrankungen | |
| EP0727994A4 (de) | Antipyretische und analgetische verfahren und zusammensetzungen, die optisch reines r-etodolac enthalten | |
| MY139368A (en) | Novel cyclohexyl sulphones | |
| DK1242410T3 (da) | Nye forbindelser | |
| DE59902666D1 (de) | Edelfosin zur behandlung von hirntumoren | |
| ATE321045T1 (de) | Methoden und zusammensetzungen zur behandlung von schmerzen | |
| MD1521F2 (en) | Methods of thrombus forming inhibition, methods of treatment of thrombotic states, pharmaceutical compositions and kit for treatment of thrombotic states | |
| NO20000771D0 (no) | Anvendelse av fankinon for behandling av Alzheimers sykdom | |
| ATE81462T1 (de) | Glykosaminoglykan zur behandlung von diabetischer mikroangiopathie. | |
| ATE26841T1 (de) | Verbindungen zur behandlung von erhoehtem blutdruck. | |
| ATE294584T1 (de) | Verwendung von desoxypeganin zur behandlung von alzheimerischer demenz | |
| ATE293972T1 (de) | Behandlung von chronischen schmerzen | |
| ATE252903T1 (de) | Arzneimittel zur behandlung konvulsivischer zustände | |
| ATE302009T1 (de) | Ubichinon qn zur behandlung von migräneschmerzen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1181012 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |